Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.

Blood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

Radiologia Medica, published by Springer-Verlag Italia SRL, is a premier Italian journal dedicated to the field of radiology, nuclear medicine, and imaging. With a rich history dating back to 1947, this journal has consistently provided cutting-edge research and findings, contributing significantly to advancements in medical imaging techniques and practices. As evidenced by its impressive Q1 rankings in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine and Imaging, Radiologia Medica holds a prestigious position within the top tier of medical journals, ranked #11 out of 333 in its category and residing in the 96th percentile according to Scopus metrics. Although it is not currently offered as an Open Access journal, its robust subscription model supports extensive research dissemination. Researchers, professionals, and students alike will find invaluable insights and knowledge critical for advancing their understanding and practice within this dynamic field. Situated in Milan, Italy, Radiologia Medica continues to be an influential platform for the exchange of high-quality research, bridging various disciplines and promoting excellence in radiological science.

SEMINARS IN INTERVENTIONAL RADIOLOGY, published by Thieme Medical Publishers Inc, is a pivotal peer-reviewed journal in the fields of interventional radiology, cardiology, and cardiovascular medicine. With a legacy spanning from 1984 to 2024, this journal serves as an essential resource for professionals seeking to advance their understanding of minimally invasive procedures and imaging techniques. Although it operates under a non-open access model, SEMINARS IN INTERVENTIONAL RADIOLOGY is committed to disseminating high-quality research and clinical insights, thus contributing to ongoing developments in effective medical practices. It enjoys a respectable position within the academic community, indicated by its 2023 rankings of Q3 in both cardiology and radiology categories, reflecting its relevance and influence in the respective fields. This journal not only addresses current trends and challenges but also aims to foster collaboration among researchers and clinicians, emphasizing the importance of evidence-based practices in improving patient outcomes.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, published by Springer, serves as a pivotal platform for advancements in the field of cardiac electrophysiology. With an ISSN of 1383-875X and an E-ISSN of 1572-8595, this esteemed journal has carved out its niche since its inception in 1997, continuing to disseminate critical research up to 2024. Ranked in the Q2 category for Cardiology and Cardiovascular Medicine, as well as in Physiology (medical), the journal is positioned among the top 38% and 53% of its respective fields according to Scopus rankings. This presents a unique opportunity for researchers, healthcare professionals, and students to engage with high-impact studies that drive innovation and knowledge in cardiac health. Although not open access, the journal is accessible through various academic databases, making it a valuable resource for those committed to understanding and enhancing interventional practices in cardiology.

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Cancer Radiotherapie, published by Elsevier, is a respected academic journal dedicated to advancing the field of oncology and radiology through original research and comprehensive reviews. With an ISSN of 1278-3218 and an E-ISSN of 1769-6658, the journal serves as a vital platform for disseminating knowledge and innovation in cancer treatment methodologies, specifically focusing on radiotherapy. As of 2023, it holds a Category Quartile of Q3 in both Oncology and Radiology, Nuclear Medicine and Imaging, reflecting its significance within these domains amidst a competitive landscape. Despite its current rankings—205th out of 333 in Radiology and 269th out of 404 in Oncology—it continuously strives to build a reputable presence with contributions that push the boundaries of cancer therapy. Although open access options are not available, the journal is committed to ensuring that valuable insights reach healthcare professionals and researchers worldwide, contributing to improved patient outcomes and advancements in treatment efficacy.